NDC product
NeoTuss Plus
NDC 12539-779 · DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals
Key facts
| Product NDC | 12539-779 |
|---|---|
| Proprietary name | NeoTuss Plus |
| Nonproprietary name | Dextromethorphan HBr, Chlorpheniramine Maleate, Phenylephrine HCl |
| Substances | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] and 2 more |
| Marketing start | Feb 28, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: